Glucagon-like peptide receptor agonists (GLP-1RAs) like Novo Nordisk’s semaglutide (Ozempic, Wegovy) and Eli Lilly’s ...
Malgré les reculs politiques, de nombreuses grandes entreprises européennes publient déjà leurs reportings CSRD.
Novo Nordisk is seeking as much as US$830 million in damages in a Singapore court, saying it was misled by a local biotech ...
Long-term investments in top tech, health, and consumer staples for stability, growth, and reliable returns. Read what ...
A lawsuit filed in the Singapore International Commercial Court is seeking $830 million in damages from KBP, with Novo ...
While the issue has fallen from the headlines after several moves to cap the cost, some patients with diabetes still often ...
Between 2018 and 2024, China has launched 188 domestically developed innovative drugs – nearly double the number from the ...
Current weight-loss methods such as lifestyle changes, surgery, and popular therapies like Novo Nordisk's Wegovy and Eli ...
Novo Nordisk is seeking up to US$830 million ($1.3 billion) in damages from KBP Biosciences arguing it was misled by the ...
Doctors say drugs that improve muscle mass could benefit older or infirm people at greater risk of falls and fractures ...
Fund Of The Week quizzes fund managers about how they’re investing your money. If you’d like to suggest which funds you want ...
Amity University Madhya Pradesh hosted its Convocation Ceremony for its class of 2024 in a grand and dignified atmosphere, on ...